Use of mva to treat prostate cancer

• 收藏
• 分享

专利权人:

BAVARIAN NORDIC INC.

发明人:

DELCAYRE ALAIN,LAUS REINER,MANDL STEFANIE,ROUNTREE RYAN,LEGRAND FATEMA

申请号：

NZ60182708

公开号：

NZ601827A

申请日:

2008.10.16

申请国别(地区):

NZ

年份:

2014

代理人:

摘要：

601827 Discloses a recombinant MVA virus expressing a polypeptide comprising human prostatic acid phosphatase (PAP) antigen, wherein the virus is MVA-BN as deposited under ECACC accession number V00083008. Also discloses the use of the virus with the PAP antigen in a medicament for inducing B cell and T cell immune responses against PAP, where the medicament is formulated for administering one or more boosting doses of the MVA/PAP virus.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/